Literature DB >> 29511320

Preadipocytes from obese humans with type 2 diabetes are epigenetically reprogrammed at genes controlling adipose tissue function.

Emil Andersen1, Lars Roed Ingerslev1, Odile Fabre1, Ida Donkin1, Ali Altıntaş1, Soetkin Versteyhe1, Thue Bisgaard2, Viggo B Kristiansen2, David Simar3, Romain Barrès4.   

Abstract

BACKGROUND: Deterioration of the adipogenic potential of preadipocytes may contribute to adipose tissue dysfunction in obesity and type 2 diabetes (T2D). Here, we hypothesized that extracellular factors in obesity epigenetically reprogram adipogenesis potential and metabolic function of preadipocytes.
METHODS: The transcriptomic profile of visceral adipose tissue preadipocytes collected from Lean, Obese and Obese with T2D was assessed throughout in vitro differentiation using RNA sequencing. Reduced Representation Bisulfite Sequencing was used to establish the genome-wide DNA methylation profile of human preadipocytes and 3T3-L1 preadipocytes treated by the inflammatory cytokine Tumour Necrosis Factor-α (TNF-α) or palmitate.
RESULTS: While preadipocytes from all obese subjects (Obese+Obese T2D), compared to those of Lean, were transcriptionally different in response to differentiation in culture, preadipocytes from Obese T2D showed impaired insulin signalling and a further transcriptomic shift towards altered adipocyte function. Cultures with a lower expression magnitude of adipogenic genes throughout differentiation (PLIN1, CIDEC, FABP4, ADIPOQ, LPL, PDK4, APOE, LIPE, FABP3, LEP, RBP4 and CD36) were associated with DNA methylation remodelling at genes controlling insulin sensitivity and adipocytokine signalling pathways. Prior incubation of 3T3-L1 preadipocytes with TNF-α or palmitate markedly altered insulin responsiveness and metabolic function in the differentiated adipocytes, and remodelled DNA methylation and gene expression at specific genes, notably related to PPAR signalling.
CONCLUSIONS: Our findings that preadipocytes retain the memory of the donor in culture and can be reprogrammed by extracellular factors support a mechanism by which adipocyte precursors are epigenetically reprogrammed in vivo. Epigenetic reprogramming of preadipocytes represents a mechanism by which metabolic function of visceral adipose tissue may be affected in the long term by past exposure to obesity- or T2D-specific factors.

Entities:  

Mesh:

Year:  2018        PMID: 29511320     DOI: 10.1038/s41366-018-0031-3

Source DB:  PubMed          Journal:  Int J Obes (Lond)        ISSN: 0307-0565            Impact factor:   5.095


  15 in total

1.  Afadin is a scaffold protein repressing insulin action via HDAC6 in adipose tissue.

Authors:  Morten Lundh; Patricia Ss Petersen; Marie S Isidor; Dolly Nm Kazoka-Sørensen; Kaja Plucińska; Farnaz Shamsi; Cathrine Ørskov; Marco Tozzi; Erin L Brown; Emil Andersen; Tao Ma; Ulrich Müller; Romain Barrès; Viggo B Kristiansen; Zachary Gerhart-Hines; Yu-Hua Tseng; Brice Emanuelli
Journal:  EMBO Rep       Date:  2019-07-02       Impact factor: 8.807

2.  Developmental programming: Prenatal testosterone-induced changes in epigenetic modulators and gene expression in metabolic tissues of female sheep.

Authors:  Xingzi Guo; Muraly Puttabyatappa; Steven E Domino; Vasantha Padmanabhan
Journal:  Mol Cell Endocrinol       Date:  2020-06-17       Impact factor: 4.102

Review 3.  Stromal Vascular Fraction for Knee Osteoarthritis - An Update.

Authors:  José Fábio Santos Duarte Lana; Anna Vitória Santos Duarte Lana; Lucas Furtado da Fonseca; Marcelo Amaral Coelho; Guilherme Gabriel Marques; Tomas Mosaner; Lucas Leite Ribeiro; Gabriel Ohana Marques Azzini; Gabriel Silva Santos; Eduardo Fonseca; Marco Antonio Percope de Andrade
Journal:  J Stem Cells Regen Med       Date:  2022-04-05

4.  Exercise training alters the genomic response to acute exercise in human adipose tissue.

Authors:  Odile Fabre; Lars R Ingerslev; Christian Garde; Ida Donkin; David Simar; Romain Barrès
Journal:  Epigenomics       Date:  2018-04-19       Impact factor: 4.778

5.  Hyperglycemia Changes Expression of Key Adipogenesis Markers (C/EBPα and PPARᵞ)and Morphology of Differentiating Human Visceral Adipocytes.

Authors:  Ewa Świderska; Marta Podolska; Justyna Strycharz; Marzena Szwed; Halina Abramczyk; Beata Brożek-Płuska; Adam Wróblewski; Janusz Szemraj; Ireneusz Majsterek; Józef Drzewoski; Agnieszka Śliwińska
Journal:  Nutrients       Date:  2019-08-08       Impact factor: 5.717

6.  Adipose Tissue Epigenetic Profile in Obesity-Related Dysglycemia - A Systematic Review.

Authors:  Sara Andrade; Tiago Morais; Ionel Sandovici; Alexandre L Seabra; Miguel Constância; Mariana P Monteiro
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-29       Impact factor: 5.555

7.  Perinatal exposure to nicotine alters spermatozoal DNA methylation near genes controlling nicotine action.

Authors:  Ali Altıntaş; Jie Liu; Odile Fabre; Tsai-Der Chuang; Ying Wang; Reiko Sakurai; Galal Nazih Chehabi; Romain Barrès; Virender K Rehan
Journal:  FASEB J       Date:  2021-07       Impact factor: 5.834

8.  Hyperglycemia Affects miRNAs Expression Pattern during Adipogenesis of Human Visceral Adipocytes-Is Memorization Involved?

Authors:  Justyna Strycharz; Ewa Świderska; Adam Wróblewski; Marta Podolska; Piotr Czarny; Janusz Szemraj; Aneta Balcerczyk; Józef Drzewoski; Jacek Kasznicki; Agnieszka Śliwińska
Journal:  Nutrients       Date:  2018-11-15       Impact factor: 5.717

9.  GPS2 Deficiency Triggers Maladaptive White Adipose Tissue Expansion in Obesity via HIF1A Activation.

Authors:  Karima Drareni; Raphaëlle Ballaire; Serena Barilla; Mano J Mathew; Amine Toubal; Rongrong Fan; Ning Liang; Catherine Chollet; Zhiqiang Huang; Maria Kondili; Fabienne Foufelle; Antoine Soprani; Ronan Roussel; Jean-François Gautier; Fawaz Alzaid; Eckardt Treuter; Nicolas Venteclef
Journal:  Cell Rep       Date:  2018-09-11       Impact factor: 9.423

10.  Development and validation of a 4-gene combination for the prognostication in lung adenocarcinoma patients.

Authors:  Xiao-Hong Yin; Li-Ping Yu; Xiao-Hong Zhao; Qin-Mei Li; Xiao-Ping Liu; Li He
Journal:  J Cancer       Date:  2020-01-29       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.